Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-64,300
Closed -$1.65M 4890
2024
Q1
$1.65M Buy
+64,300
New +$1.61M ﹤0.01% 2773
2023
Q3
Sell
-154,000
Closed -$3.61M 4530
2023
Q2
$3.61M Sell
154,000
-91,000
-37% -$1.54M ﹤0.01% 2122
2023
Q1
$2.91M Buy
+245,000
New +$3.49M ﹤0.01% 2404
2022
Q1
Sell
-9,200
Closed -$264K 5997
2021
Q4
$264K Hold
9,200
﹤0.01% 4741
2021
Q3
$370K Buy
+9,200
New +$411K ﹤0.01% 4245

Other funds holding XP

D.E. Shaw & Co's XP Position: Q1 2026 in Review

D.E. Shaw & Co reduced its XP (XP) stake by 64% in Q1 2026, selling an estimated $3.69M and leaving 105,532 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since. The position peaked at $92M in Q4 2023. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • D.E. Shaw & Co held 105,532 shares of XP worth $2.01M as of Q1 2026.
  • D.E. Shaw & Co sold 190,959 XP shares in Q1 2026, an estimated $3.69M.
  • XP made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2907 holding.
  • D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since.
  • D.E. Shaw & Co's XP position peaked at $92M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.